| mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |
| mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0001 |
| mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0001 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0002 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0004 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0009 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |